How the MHRA processes variations to marketing authorisations.
Similar Posts
Side effects from drug interactions to be predicted by AI before reaching patients
The MHRA leads three new government-backed projects using AI-driven approaches to make medicines safer and bring treatments to patients more quickly.
Professor Alastair Denniston: The future regulation of AI in healthcare
Creating a framework that is safe, fast and trusted.
Corporate report: Medicines and Healthcare Products Regulatory Agency Annual Report and Accounts 2024 to 2025
MHRA annual report and accounts 2024 to 2025.
Medical devices regulations: targeted consultation on the indefinite recognition of CE marked devices
This consultation invites views on proposals for recognising CE marked medical devices in Great Britain.
Guidance: Human medicines Modular Manufacture and Point of Care regulations 2025: Overview
Helping interpret the Human Medicines (Amendment) Modular Manufacture and Point of Care regulations 2025.
Professor Bola Owolabi CBE: Creating the Climate for Health Equity
Exploring the MHRA’s transformational impact on access, experience, and outcomes.